SecBot SecBot
425 ·Filed Jul 20, 2026

PSNL

Personalis, Inc.
BULLISH
Impact 7/10
Horizonweeks Processed3mo ago SEC0001193125-26-309106
Rule 425 M&A communications
Actionable Insight ▲ Bullish

Monitor Tempus (TEM) stock price as it determines actual consideration for PSNL holders. Key milestones: filing of S-4, stockholder vote, and HSR clearance. If TEM stays above $48.42, PSNL holders benefit from stock upside; if it falls below $46, PSNL can walk away. The deal appears well-structured with Merck support, but regulatory risk remains.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$13.44
T+0 close · Jul 20, 2026 · via day close
Latest settled
+17.93%
T+60 · $15.85
Vs SPY
+13.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 21 $13.44entry
  2. T+1 · 4mo ago −7.22%α −7.10% · $12.47
  3. T+5 · 4mo ago −10.86%α −9.63% · $11.98
  4. T+20 · 3mo ago +3.50%α +0.94% · $13.91
  5. T+60 · 5w ago +17.93%α +13.96% · $15.85
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Personalis (PSNL) entered into a definitive merger agreement with Tempus AI (TEM) on July 20, 2026. PSNL shareholders will receive $16.25 per share in Tempus stock (variable exchange ratio, floored at 0.3356 if TEM ≤ $48.42), with Tempus having the option to pay cash for up to 50% of shares. Merck, holding ~13% of PSNL, has agreed to vote in favor. The deal is expected to close in late 2026 or early 2027, subject to stockholder approval, HSR clearance, and other conditions.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Definitive merger agreement with Tempus AI: PSNL shareholders receive $16.25 per share in Tempus stock (exchange ratio variable with floor of 0.3356).
  • Tempus may elect to pay cash for up to 50% of outstanding PSNL shares at $16.25 per share.
  • Merck (~13% holder) entered into a voting agreement to support the deal.
  • Mutual termination fee of approximately $76.8 million each way.
  • PSNL has the right to terminate if Tempus stock price falls below $46.00 (Lower Floor Price).
  • Closing conditions include stockholder approval, HSR clearance, S-4 effectiveness, and tax opinion.

Financial Impact

Consideration valued at $16.25 per share (~6% premium to prior close, 28% premium to 30-day VWAP per prior analysis); total enterprise value ~$1.5B.

stock pricedeal considerationdilution

Risk Factors

  • Stockholder approval may fail (though Merck's 13% vote helps).
  • Antitrust (HSR) clearance could be delayed or blocked.
  • Tempus stock price decline below $46 could lead to PSNL termination.
  • Integration risk and potential business disruption post-close.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001193125-26-309106
Document: 0001193125-26-309106-index-headers.html0001193125-26-309106
Document: 0001193125-26-309106-index.html0001193125-26-309106
Document: 0001193125-26-309106.txt0001193125-26-309106

Track record

29 reports on PSNL

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +18.82% at T+60 after the Jul 20, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.16 Now $14.80 −2.34% settles Feb 12
  2. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $15.71 Now $14.80 −5.79% settles Feb 11
  3. Nov 12, 20264d ago 425 Neutral 4/10 Entry $15.86 Now $14.80 −6.68% settles Feb 10
  4. Nov 6, 202610d ago 425 Neutral 3/10 Entry $15.95 Now $14.80 −7.21% settles Feb 5
  5. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $15.55 Now $14.80 −4.82% settles Feb 3
  6. Nov 3, 202613d ago 425 Neutral 3/10 Entry $15.79 Now $14.80 −6.27% settles Feb 2
  7. Oct 30, 202617d ago 425 Neutral 4/10 Entry $15.76 Now $14.80 −6.09% settles Jan 29
  8. Oct 21, 202626d ago DEFM14A Neutral 5/10 Entry $15.82 Now $14.80 −6.45% settles Jan 20
  9. Oct 20, 202627d ago 425 Neutral 4/10 Entry $15.90 Now $14.80 −6.92% settles Jan 19
  10. Oct 20, 202627d ago 425 Neutral 5/10 Entry $15.90 Now $14.80 −6.92% settles Jan 19
Showing 10 of 29

US Market Status

Market Closed · Opens in 8h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026